Can smarter remote monitoring keep heart failure patients out of the hospital?

NCT ID NCT03012490

Completed Disease control Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 652 heart failure patients who had a special heart device (CRT). One group received standard remote monitoring, while the other got more detailed monitoring that also tracked heart rhythm issues and symptoms. The goal was to see if the extra monitoring could reduce deaths or hospital visits for worsening heart failure over 27 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: remote monitoring (comprehensive vs standard)
What this could lead to: If successful, this could show that more detailed remote monitoring helps heart failure patients live longer and avoid hospital stays.
What could go wrong: This trial is already completed, so results are known. The approach may not significantly improve outcomes over standard care, and benefits may vary by patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC RESYNCHRONIZATION THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC RESYNCHRONIZATION THERAPY HEART FAILURE

Contacts and locations

Locations

Institut coeur poumon, CHRU

Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.